Detailed answers about GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED founded?
GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED was officially incorporated on 21 June 2021 and is registered under company number 13469549. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED?
GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED do?
GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED's registered address?
The registered office address of GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED is C/O SG ACCOUNTING 1 CEDAR OFFICE PARK, COBHAM ROAD, WIMBORNE, UNITED KINGDOM, BH21 7SB. This is the official address filed with Companies House for legal and statutory correspondence.
Is GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED financially stable?
The most recent accounts for GENTLE WAVE MEDICAL COMMUNICATIONS LIMITED were made up to 30 June 2025, filed as MICRO ENTITY. Next accounts are due by 31 March 2027.